Future directions in vitamin D and cardiovascular research

作者: A. Zittermann , J. Börgermann , J.F. Gummert , S. Pilz

DOI: 10.1016/J.NUMECD.2012.02.004

关键词:

摘要: Abstract Aims Evidence is accumulating that vitamin D status may influence the risk of cardiovascular disease (CVD). Final confirmation for a causal relationship between and CVD however still lacking. The present viewpoint article outlines several future research directions to close this gap. Data synthesis Future include need performing large randomised controlled supplementation trials with in specific groups. In addition, register sets data on can be used, provided adequate statistical methods such as propensity score modelled analysis are applied. To better understand D-mediated effects risk, routine measurement circulating levels hormonal form, 1,25-dihydroxyvitamin D, also necessary, addition determination its precursor 25-hydroxyvitamin D. Further, genetic association studies help clarifying contribution development CVD. Finally, interrelationship physical activity should considered when studying risk. Conclusions Overall, it expected next 10–15 years will provide an increased clarity concerning role

参考文章(48)
Ovesen L, Andersen R, Brot C, Towards a strategy for optimal vitamin D fortification (OPTIFORD). Nutrition Metabolism and Cardiovascular Diseases. ,vol. 11, pp. 74- ,(2001)
Andreas Tomaschitz, Stefan Pilz, Eberhard Ritz, Tanja Grammer, Christiane Drechsler, Bernhard O. Boehm, Winfried März, Independent association between 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin-angiotensin system: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Clinica Chimica Acta. ,vol. 411, pp. 1354- 1360 ,(2010) , 10.1016/J.CCA.2010.05.037
Reinhold Vieth, Donald Fraser, Sang Whay Kooh, Low dietary calcium reduces 25-hydroxycholecalciferol in plasma of rats. Journal of Nutrition. ,vol. 117, pp. 914- 918 ,(1987) , 10.1093/JN/117.5.914
Heather B Del Valle, A Catharine Ross, Ann L Yaktine, Christine L Taylor, Dietary Reference Intakes for Calcium and Vitamin D ,(2013)
Claudio Ronco, Mario Cozzolino, Mineral metabolism abnormalities and vitamin D receptor activation in cardiorenal syndromes. Heart Failure Reviews. ,vol. 17, pp. 211- 220 ,(2012) , 10.1007/S10741-011-9232-8
Lenneke van Groningen, Susanne Opdenoordt, Adriaan van Sorge, Darryl Telting, Astrid Giesen, Hans de Boer, Cholecalciferol loading dose guideline for vitamin D deficient adults European Journal of Endocrinology. ,vol. 162, pp. 805- 811 ,(2010) , 10.1530/EJE-09-0932
Laufey Steingrimsdottir, Orvar Gunnarsson, Olafur S Indridason, Leifur Franzson, Gunnar Sigurdsson, None, Relationship Between Serum Parathyroid Hormone Levels, Vitamin D Sufficiency, and Calcium Intake JAMA. ,vol. 294, pp. 2336- 2341 ,(2005) , 10.1001/JAMA.294.18.2336
Elena Kamycheva, Johan Sundsfjord, Rolf Jorde, Serum parathyroid hormone levels predict coronary heart disease: the Tromsø Study European Journal of Preventive Cardiology. ,vol. 11, pp. 69- 74 ,(2004) , 10.1097/01.HJR.0000114706.27531.01
Armin Zittermann, Uwe Fuchs, Joachim Kuhn, Jens Dreier, Uwe Schulz, Jan F. Gummert, Jochen Börgermann, Parameters of mineral metabolism predict midterm clinical outcome in end-stage heart failure patients. Scandinavian Cardiovascular Journal. ,vol. 45, pp. 342- 348 ,(2011) , 10.3109/14017431.2011.611250
Orlando M. Gutiérrez, Michael Mannstadt, Tamara Isakova, Jose Alejandro Rauh-Hain, Hector Tamez, Anand Shah, Kelsey Smith, Hang Lee, Ravi Thadhani, Harald Jüppner, Myles Wolf, Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. The New England Journal of Medicine. ,vol. 359, pp. 584- 592 ,(2008) , 10.1056/NEJMOA0706130